Ryan Zimmerman
Stock Analyst at BTIG
(3.77)
# 690
Out of 5,161 analysts
241
Total ratings
48.8%
Success rate
8.15%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SI Shoulder Innovations | Maintains: Buy | $23 → $24 | $14.01 | +71.31% | 2 | Mar 11, 2026 | |
| KIDS OrthoPediatrics | Maintains: Buy | $23 → $24 | $17.80 | +34.83% | 11 | Feb 27, 2026 | |
| ORGO Organogenesis Holdings | Maintains: Buy | $9 → $8 | $2.67 | +199.63% | 11 | Feb 27, 2026 | |
| SOLV Solventum | Reiterates: Buy | $100 | $67.62 | +47.89% | 3 | Feb 27, 2026 | |
| ENOV Enovis | Maintains: Buy | $41 → $43 | $24.84 | +73.11% | 2 | Feb 26, 2026 | |
| ALC Alcon | Maintains: Buy | $91 → $92 | $80.77 | +13.90% | 14 | Feb 25, 2026 | |
| GKOS Glaukos | Reiterates: Buy | $131 | $102.86 | +27.36% | 17 | Feb 18, 2026 | |
| TCMD Tactile Systems Technology | Maintains: Buy | $36 → $38 | $27.86 | +36.40% | 6 | Feb 18, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Buy | $112 | $93.73 | +19.49% | 11 | Feb 10, 2026 | |
| MDAI Spectral AI | Reiterates: Buy | $3 | $1.37 | +118.98% | 3 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.19 | +404.20% | 7 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $91 | $72.65 | +25.26% | 6 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $412 | $345.78 | +19.15% | 19 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $616 | $492.87 | +24.98% | 23 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $349 | $336.11 | +3.84% | 21 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $11.70 | +105.13% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.80 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1.5 | $0.63 | +139.23% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.39 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $75.41 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $119.64 | +62.99% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.88 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $27.80 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $110.25 | +34.24% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.39 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $87.17 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $9.61 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $17.66 | +200.11% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.27 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $175.47 | +13.98% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $238.82 | +46.55% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $88.97 | +43.87% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.79 | +27.23% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.22 | +143.90% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $6.49 | +708.94% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.29 | - | 3 | Apr 2, 2020 |
Shoulder Innovations
Mar 11, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $14.01
Upside: +71.31%
OrthoPediatrics
Feb 27, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $17.80
Upside: +34.83%
Organogenesis Holdings
Feb 27, 2026
Maintains: Buy
Price Target: $9 → $8
Current: $2.67
Upside: +199.63%
Solventum
Feb 27, 2026
Reiterates: Buy
Price Target: $100
Current: $67.62
Upside: +47.89%
Enovis
Feb 26, 2026
Maintains: Buy
Price Target: $41 → $43
Current: $24.84
Upside: +73.11%
Alcon
Feb 25, 2026
Maintains: Buy
Price Target: $91 → $92
Current: $80.77
Upside: +13.90%
Glaukos
Feb 18, 2026
Reiterates: Buy
Price Target: $131
Current: $102.86
Upside: +27.36%
Tactile Systems Technology
Feb 18, 2026
Maintains: Buy
Price Target: $36 → $38
Current: $27.86
Upside: +36.40%
Zimmer Biomet Holdings
Feb 10, 2026
Reiterates: Buy
Price Target: $112
Current: $93.73
Upside: +19.49%
Spectral AI
Feb 10, 2026
Reiterates: Buy
Price Target: $3
Current: $1.37
Upside: +118.98%
Feb 9, 2026
Reiterates: Buy
Price Target: $6
Current: $1.19
Upside: +404.20%
Feb 9, 2026
Reiterates: Buy
Price Target: $91
Current: $72.65
Upside: +25.26%
Jan 30, 2026
Maintains: Buy
Price Target: $410 → $412
Current: $345.78
Upside: +19.15%
Jan 23, 2026
Reiterates: Buy
Price Target: $616
Current: $492.87
Upside: +24.98%
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $336.11
Upside: +3.84%
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $11.70
Upside: +105.13%
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $4.80
Upside: -
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.63
Upside: +139.23%
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.39
Upside: -
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $75.41
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $119.64
Upside: +62.99%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $32.88
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $27.80
Upside: -
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $110.25
Upside: +34.24%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.39
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $87.17
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $9.61
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $17.66
Upside: +200.11%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $12.27
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $175.47
Upside: +13.98%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $238.82
Upside: +46.55%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $88.97
Upside: +43.87%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $11.79
Upside: +27.23%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.22
Upside: +143.90%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $6.49
Upside: +708.94%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $32.29
Upside: -